Sitemap

• Home
• DSM at a glance
• Key data for 2010
• Key data
• Letter from the Chairman
• DSM in motion: driving focused growth
• Report by the Managing Board
  • Highlights of 2010
  • Vision 2010
  • Sustainability strategy
  • People in 2010
  • Planet in 2010
  • Profit in 2010
  • Outlook
  • Financial policy
  • Innovation
  • External recognition
• Review of business
  • Life Sciences
  • Nutrition
  • Pharma
  • Materials Sciences
  • Performance Materials
  • Polymer Intermediates
  • Other activities
• Corporate governance and risk management
  • Introduction
  • Dutch corporate governance code
  • Governance framework
  • Risk management
  • Statements of the Managing Board
• Report by the Supervisory Board
  • Supervisory Board report
  • Remuneration policy regarding the Managing Board and the Supervisory Board
• Supervisory Board and Managing Board
• What still went wrong
• Information about the DSM share
• Consolidated financial statements
  • Summary of significant accounting policies
  • Consolidated statements
  • Notes to the consolidated financial statements of Royal DSM N.V.
    • 1 General information
    • 2 Change in the scope of the consolidation
    • 3 Segment information
    • 4 Total costs
    • 5 Net finance costs
    • 6 Exceptional items
    • 7 Income tax
    • 8 Intangible assets
    • 9 Property, plant and equipment
    • 10 Associates
    • 11 Other financial assets
    • 12 Inventories
    • 13 Receivables
    • 14 Current investments
    • 15 Cash and cash equivalents
    • 16 Equity
    • 17 Provisions
    • 18 Borrowings
    • 19 Other non-current liabilities
    • 20 Current liabilities
    • 21 Contingent liabilities and other financial obligations
    • 22 Financial instruments and risks
    • 23 Post-employment benefits
    • 24 Net debt
    • 25 Notes to the cash flow statement
    • 26 Share-based compensation
    • 27 Interests in joint ventures
    • 28 Interests in associates
    • 29 Related parties
    • 30 Service fees paid to external auditors
• Financial statements of Royal DSM N.V.
  • Notes to the Royal DSM N.V. financial statements
    • 1 General
    • 2 Intangible assets
    • 3 Property, plant and equipment
    • 4 Financial assets
    • 5 Receivables
    • 6 Royal DSM N.V. Shareholders' equity
    • 7 Provisions
    • 8 Borrowings
    • 9 Other current liabilities
    • 10 Remuneration of the members of the Managing Board
    • 11 Remuneration of the members of the Supervisory Board
• Other information
  • Independent Assurance Report on People and Planet
  • Independent Auditor's Report on the Financial Statements
  • Profit appropriation
  • Special statutory rights
• DSM figures: five-year summary
• Sustainability reporting approach
• Explanation of some concepts and ratios
• Downloads
• User Terms and Conditions Annual report